Alexion Pharmaceuticals, Inc.
NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021
ALXN Articles
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most...
Published:
Last Updated:
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most...
Published:
Last Updated:
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included AK Steel, Amgen, Booking, Chubb, Chipotle Mexican Grill, Expedia, Gilead Sciences, Goodyear, Philip Morris, Target and...
Published:
Last Updated:
The April 30 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
Published:
Last Updated:
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in...
Published:
Last Updated: